Brivaracetam and Sepsis - a phase IV clinical study of FDA data

Summary:

Sepsis is reported as a side effect among people who take Brivaracetam (brivaracetam), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Colecalciferol, and have Seizures.

The phase IV clinical study analyzes which people have Sepsis when taking Brivaracetam. It is created by eHealthMe based on reports of 3,318 people who have side effects when taking Brivaracetam from the FDA, and is updated regularly.

What is Brivaracetam?

Brivaracetam has active ingredients of brivaracetam. eHealthMe is studying from 3,319 Brivaracetam users. Check the latest studies of Brivaracetam.

What is Sepsis?

Sepsis (a severe blood infection that can lead to organ failure and death) is found to be associated with 2,523 drugs and 3,259 conditions by eHealthMe. Check the latest studies of Sepsis.

On Jul, 16, 2026

3,318 people reported to have side effects when taking Brivaracetam.
Among them, 21 people (0.63%) have Sepsis.

Among these 21 people:

How long have people been on Brivaracetam when they have Sepsis? *

What is the gender of people who have Sepsis when taking Brivaracetam? *

female: 45 %
male: 55 %

What is the age of people who have Sepsis when taking Brivaracetam? *

What are other drugs people take besides Brivaracetam? *

What are other side effects people have besides Sepsis? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 38.10%
Weakness: 7 people, 33.33%
Fatigue (feeling of tiredness): 7 people, 33.33%
Hypotension (abnormally low blood pressure): 7 people, 33.33%
Neuropathy Peripheral (surface nerve damage): 6 people, 28.57%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 6 people, 28.57%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 28.57%
Fainting (loss of consciousness and postural tone): 6 people, 28.57%
Diarrhea: 6 people, 28.57%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 28.57%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 47.62%
Cardiac Failure Congestive: 6 people, 28.57%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 14.29%
Parkinson's Disease: 2 people, 9.52%
Nausea (feeling of having an urge to vomit): 2 people, 9.52%
High Blood Pressure: 1 person, 4.76%
Back Pain: 1 person, 4.76%
Constipation: 1 person, 4.76%
Depression: 1 person, 4.76%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Brivaracetam and have Sepsis?

- Check whether Sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Brivaracetam:

Brivaracetam (3,319 reports)

Sepsis treatments and more:

Sepsis (140,102 reports)

Browse all side effects of Brivaracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis:

Sepsis (2,523 drugs)

Browse all the conditions that are associated with Sepsis:

Sepsis (3,259 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brivaracetam (the active ingredients of Brivaracetam) and Brivaracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.